Photo from wikipedia
Matching patients with pancreatic cancer to therapies based on genomic alterations in their tumors may be beneficial. In the retrospective Know Your Tumor trial, patients with alterations who were treated… Click to show full abstract
Matching patients with pancreatic cancer to therapies based on genomic alterations in their tumors may be beneficial. In the retrospective Know Your Tumor trial, patients with alterations who were treated with targeted agents lived longer than those treated with standard therapies.
Keywords:
succeeds pancreatic;
cancer;
targeted approach;
approach succeeds;
pancreatic cancer
Journal Title: Cancer discovery
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cancer discovery
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!